The researchers have applied for a patent on the method, dubbed MaPS-seq, which could be used to identify clinical biomarkers or turned into a kit.
The group will start a pilot study at Columbia University next week to sequence genes from 600 Parkinson's disease patients before expanding to a larger cohort.
In Nature this week: CRISPR-Cas9 genome editing system that does not require double-strand DNA breaks, and more.
In Science this week: somatic mutations found throughout normal tissue, and more.
The Columbia Solid Tumor Panel, a custom NGS panel from Pillar Biosciences, will be used at CUMC's Laboratory of Personalized Genomic Medicine.
A LIMS1 gene variant appeared to coincide with increased risk of allograft rejection in kidney transplant recipients.
Consumer genomics companies have endeavored to reach out to minority communities with sometimes contentious results.
In PNAS this week: core Pseudomonas aeruginosa genome, study of ancient Paget's disease of the bone, and more.
In Nature this week: genomic factors that influence glioblastoma response to anti-PD-1 therapy, sequencing test for infectious disease, and more.
A trio of researchers writes at Stat News that while editing embryos to improve IQ is not yet possible, there's already a way to predict which embryos might be the smartest.
Holden Thorp is to be the new editor-in-chief of Science and its related journals.
A genetic analysis of salmon scales collected over the course of a century points to a sharp decline in the number of fish returning each year to river in British Columbia, CBC reports.
Adelaide University has suspended the head of an ancient DNA lab as its investigation of workplace bullying continues, Australia's ABC News reports.
In PNAS this week: gene expression profiles of adipocyte subtypes, computational approach for improving plant expressome analysis, and more.